The family Amaryllidaceae has a long history of usage in the traditional medicinal practices of the indigenous peoples of South Africa, with three of its species known to be used for cancer treatment. Furthermore, the Amaryllidaceae is widely recognized for its unique alkaloid constituents, several of which exhibit potent and selective cytotoxic activities. In this study, several crinane alkaloids derived from local Amaryllidaceae species were examined for cytotoxic effects against the human cervical adenocarcinoma cell line, of which distichamine was the most potent (IC 50 2.2 M).
Behind lung and breast cancers, cervical cancer is the third most common cancer in women [1a] . In 2008, 530,000 new cases were diagnosed worldwide, 86% of which occurred in developing countries [1b] . Ten of the nations with the highest prevalence are located on the African continent, with Guinea reflecting the highest rate (56.3 per 100,000) [1b] . Over the past four decades, the rates of cervical cancer in developed nations have shown a steady decline of almost 70% [1a] . This progress is attributed largely to the implementation of rigorous education programs targeting the female population in general and adolescents in particular [1a,b] . Furthermore, the introduction of screening procedures (such as the Pap test) to detect cervical changes at the earliest and most curable stage have contributed significantly to the drastic decline in the number of cases and mortality from cervical cancer [1a,b] . In support of this, it has been shown that there is a high 5-year survival rate (up to 100%) in individuals disposed to early detection followed by therapeutic intervention [1a-c,2] . Despite these measures, the number of new cases is set to grow to about 1 million per annum by 2030 [1c] .
Given the vast resource platform afforded by the plant kingdom in drug discovery, it is not surprising that up to 60% of anti-cancer drugs in clinical use are derived from plants [3] . The plant family Amaryllidaceae has long been known for its use in the traditional remediation of cancer [4] [5] [6] [7] . For centuries, this has been a theme common in the traditional medicine of the indigenous populations of the various regions of its prominence, including Asia [4] , Europe [5], South Africa [6] and South America [7] . As a consequence, alkaloid constituents of the Amaryllidaceae [6, 8] , which are its main secondary metabolites, have garnered widespread interest as potential drug targets in cancer chemotherapy due to their potent and selective cytotoxic properties [5, 9] . Chief amongst these alkaloids is the phenanthridone pancratistatin (1) (Scheme 1), which has been making steady progress in clinical trials and it has been suggested that a structurally-related drug candidate could be commercially available within the next decade [5, 9] . Over the past four decades, crinane alkaloids of the Amaryllidaceae, such as crinine (2), have been gaining impetus as cytotoxic agents due to their promising activities against various cancer cell lines [9b]. To date, over 70 such compounds have been screened against 54 different cancers [9b]. For the purpose of this study, a mini-panel of crinane alkaloids (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) obtained from South African Amaryllids was screened against human cervical adenocarcinoma (HeLa) cells, of which distichamine (7) , crinamine (9), haemanthamine (10) and haemanthidine (11) were markedly active with IC 50 s of 2. 2, 5.8, 8.3 and 13 .9 M, respectively. Furthermore, apoptosis-inducing activity is demonstrated for distichamine, thus adding to the growing body of evidence on the apoptotic properties of crinane alkaloids.
The known alkaloids (2-11) (Scheme 1) used in the cytotoxicity study were obtained from Boophone disticha (L.f.) Herb., B. haemanthoides F.M. Leight., Brunsvigia radulosa Herb. and Cyrtanthus elatus (Jacq.) Traub [10] . A full set of spectroscopic data for the apoptosis inducer distichamine (7) , including 1D and 2D NMR data is afforded in Table 1 . The 1 H and 13 C NMR data closely matched those that have been published [10c]. Distichamine (7) is unique amongst the crinane series of compounds in possessing both vinylic methoxyl as well as ,-unsaturated ketone C-ring functionalities and of all Amaryllid species examined to date, it is isolable only from the genus Boophone [6d,10c-e].
The mini-library of crinane alkaloids (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) was screened for cytotoxic effects against HeLa cells using staurosporine and galanthamine as positive and negative controls, respectively. As shown in Table 2 , the activity for distichamine (IC 50 2.2 M) as determined through the Calcein AM assay is immediately apparent. The -crinane alkaloids crinine (2), buphanisine (3), buphanidrine (4) and ambelline (5), all of which possess in common a C-1/C-2 double bond, as well as polar substitution at C-3, were inactive (IC 50 s > 50 M). This was also true for the 1,2--epoxide undulatine (6), as well as distichaminol (8) both with IC 50 s > 50 M. By contrast, the -crinane alkaloids crinamine (9), haemanthamine (10) and haemanthidine (11) were all active with IC 50 s of 5. 8, 8.3 and 13 .9 M, respectively.
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Flow cytometry was next invoked to quantify the distribution of cells across the various phases of the cell cycle. To this extent, treatment with distichamine (7) increased the proportion of G 2 /M and S phase cells in a dose-dependent manner, with a concomitant reduction in the proportion of G 0 /G 1 cells (Figure 1 ). In addition, the proportion of cells with sub-G 1 amounts of DNA (apoptotic cells) increased (up to 19 %) following a 24 h treatment relative to untreated cells. Thus, distichamine was clearly capable of cell cycle disturbance and apoptosis induction in HeLa cancer cells. A similar response was recently shown for distichamine in human lymphoblastic leukemia (CEM) cells, but in which case there was a 23.7% increase in the sub-G 1 amounts of DNA [12a] .
Apoptosis is mediated by caspase cascade activation [11a] . Caspase-3 is an executioner protease that cleaves poly ADP-ribose polymerase-1 (PARP), resulting in DNA degradation and apoptotic cell death [11b] . The activities of effector caspases-3 and -7 (3/7) were determined in HeLa cells exposed to distichamine (at 1, 10 and 20 µM) using the fluorogenic substrate Ac-DEVD-AMC and the caspase-3/7 inhibitor Ac-DEVD-CHO (see Experimental section). Distichamine (7) induced a 3-fold increase in the activity of caspase-3/7 after 24 h at the highest tested concentration (20 µM) compared with untreated controls (Figure 2 ). The marked increase in the expression of active caspase-3/7 together with the flow cytometry indicators (Figure 1) , as well as the results from immuno-detection ( Figure 3 ), confirmed that distichamine is able to induce apoptosis in HeLa cells. By contrast, in CEM cells caspase-3/7 activity was more pronounced (12.5-fold increase) after treatment with distichamine [12a] .
Western blotting was then used to detect changes in the expression of apoptosis-related proteins (Figure 3 ). Treatment with distichamine, noticeably at 10 and 20 µM, induced cleavage of PARP (89 kDa fragment) after 24 h, which also corresponded with increased caspase-3 activity ( Figure 2) . A slight decrease in the expression of anti-apoptotic protein Bcl-2 was noticeable at the 20 µM treatment mark. By contrast, a marked decrease in the level of anti-apoptotic protein Mcl-1 was observed at 20 µM, indicating the onset of apoptosis. Mcl-1 is necessary for cell viability and its decreased expression has been suggested as the cause of cell death [11c] . It also plays a crucial role in regulating the apoptosis of Tcells [11d] . Western blot analysis thus demonstrated the dosedependent cleavage of PARP by distichamine (7) in HeLa cells, indicating that the compound induces caspase-3 activity. Similarly, apoptosis-inducing effects, demonstrated via caspase-3 activation and PARP cleavage, has recently been described for distichamine in CEM cells [12a] . However, the most striking difference between distichamine-induced apoptosis in CEM and HeLa cells lies with the lack of expression of the tumor suppressor protein p53 in the latter. This is understandable since HeLa cells are generally HPVcompromised and the function of p53 is thus abrogated.
Crinine (2), buphanidrine (4), ambelline (5) and haemanthamine (10) were initially screened for activity against HeLa cells by Jimenez and co-workers in 1976 [12b]. Of these, haemanthamine was shown to be the most active (MIC 4 M), while the rest of the compounds exhibited no inhibitory effects at concentrations up to 0.4 mM [12b], consistent with the findings of the present study ( Table 2) . Table 1 : 1D and 2D NMR spectroscopic data for distichamine (7) .
Position    C COSY HMBC NOESY 1 -201.9 (s) --- Activities observed here for crinamine (9) (IC 50 5.8 M) and haemanthidine (11) (IC 50 13.9 M) are not unexpected given their close structural similarity to haemanthamine (10), as well as their cytotoxic activities against several other cancer cells [9b] . Of the other -crinane alkaloids (12 and 14-24) previously tested against the HeLa cell line, only bulbispermine (15) exhibited strong activity (GI 50 8 M) [12c] . In accordance with the present result (Table 2) , the -crinane buphanisine (3) was previously shown to be inactive towards HeLa cells (GI 50 > 100 M) [12c]. The result for undulatine (6) ( Table 2) is noteworthy in that it is only the second occasion that this alkaloid has been screened against any cancer cells, previously being shown to be inactive against OE21 esophageal squamous carcinoma [12d]. The activity shown here for distichaminol (8) (IC 50 > 50 M) ( Table 2) , as well as that previously reported for buphanamine (13) (GI 50 > 100 M)
[12c] are somewhat surprising given their close structural proximity to distichamine (7), uncovered here as a potent inducer of apoptosis in HeLa cells. These findings thus point to the unique C-ring structural features of distichamine, including its ,-unsaturated ketone as well as vinylic methoxyl functionalities, which have been shown to be crucial to its apoptosis-inducing pharmacophore [12a] .
In addition to this, apoptosis-inducing effects have been described for other crinane alkaloids (2) via oligonucleosomal DNA fragmentation revealed the apoptotic cell death mode as responsible for its cytotoxicity [12g] . However, these studies [12eg] failed to provide a mechanistic basis for these effects. This therefore brings into focus the significance of our present and previous [12a] findings in which a mechanistic rationale to the apoptosis-inducing effects of crinane alkaloids is supported by convincing biochemical evidence.
In summary, evaluation of a mini-library comprising eight crinane alkaloids of the Amaryllidaceae against HeLa cells revealed distichamine, crinamine, haemanthamine and haemanthidine as potent cytotoxic agents with IC 50 values in the range 2.213.9 M. Distichamine is uncovered as the most potent of the compounds screened, with apoptosis-inducing activity, as shown via caspase-3 activation and PARP cleavage. It is distinguished from the other compounds in the mini-library by its unique C-ring structural formulation which is shown to be significant as an essential pharmacophoric component. Efforts to further unravel the features associated with this apoptosis-inducing pharmacophore are ongoing in our laboratories. (7) compared with their expression in untreated control cells. The expression of -actin was monitored as a protein loading control. (2) > 50 Buphanisine (3) > 50 Buphanidrine (4) > 50 Ambelline (5) > 50 Undulatine (6) > 50 Distichamine (7) 2.2 ± 0.1 Distichaminol (8) > 50 Crinamine (9) 5.8 ± 0.4 Haemanthamine (10) 8.3 ± 0.4 Haemanthidine (11) 13.9 ± 2.0 Staurosporine d 0.175 ± 0.007 Galanthamine e > 50 a All compounds were single entities as shown by TLC, HPLC and NMR analysis. b Cells were treated for 72 h with serial concentrations of samples. c Values are means of at least three independent experiments performed in triplicate, with standard deviation as indicated. d,e Staurosporine and galanthamine used as positive and negative controls, respectively.
Experimental
General: Melting points (uncorrected) were measured on a Gallenkamp melting point apparatus. Optical rotations were determined on a Perkin-Elmer 241 polarimeter installed with a  589 sodium lamp. Circular dichroism (CD) spectra were obtained with a Jasco J-700 spectropolarimeter. IR spectra were measured on a Bio-Rad FTS-40 series spectrometer in dry film. EIMS were run on a Micromass Quattro Ultima spectrometer fitted with a direct injection probe (DIP) with ionization energy set at 70 eV and HRMS (ES) were performed with a Micromass Q-Tof Ultima spectrometer. 1 H, 13 C NMR, DEPT, COSY, NOESY, HSQC and HMBC spectra were recorded on a Bruker AV400 in either CDCl 3 or CD 3 OD; chemical shifts are reported in units of  (ppm) and coupling constants (J) are expressed in Hz. Silica gel Merck KGaA (70-230 mesh) was used for CC, and TLC silica gel 60 F 254 for analyt. and prep. TLC (both Merck KGaA). Gel filtration was carried out on Sephadex LH-20 (Pharmacia). Compounds on chromatograms were detected under UV light (254 and 365 nm) and by Dragendorff's reagent stain.
